Cyto Pulse Sciences was acquired by Cellectis in September, 2010 and is no longer in operation. It was a clinical-stage medical device and treatment development company dedicated to advancing quality of life through novel electric field based technologies for oncology, gene therapy and infectious disease applications. Cyto Pulse's IP portfolio primarily focused on in vivo DNA vaccine delivery systems, tools for mAb discovery research, and large-scale cell transfection for GMP production environments.
Company Details
- Address
- 810 Cromwell Park Dr.,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- cytopulse.com
- HQ
- Glen Burnie, Maryland
Cyto Pulse Sciences, Inc. Questions
Cyto Pulse Sciences, Inc.'s website is cytopulse.com
Cyto Pulse Sciences, Inc.'s LinkedIn profile is https://www.linkedin.com/company/cyto-pulse-sciences-inc.
Cyto Pulse Sciences, Inc.'s industry is
Biotechnology Research
Cyto Pulse Sciences, Inc.'s top competitors are
Celid Biotechnologies Inc.,
Synvolux Products & Therapeutics B.v.,
Hunterian Medicine,
Novopyxis,
Generatixe, Inc.,
Pepvax,
Navera Therapeutics,
Navera,
Satreda As,
Anchor Biosciences.
Cyto Pulse Sciences, Inc.'s categories are Biotechnology Research
